Lyell Immunopharma, Inc. (LYEL)

USD 0.59

(-7.9%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 750.02 Million 937.56 Million 1.12 Billion 908.28 Million 555.63 Million
Total Current Assets 554.68 Million 651.29 Million 626.28 Million 617.54 Million 440.25 Million
Cash And Short Term Investments 546.22 Million 640.15 Million 614.79 Million 612.61 Million 436.04 Million
Cash and Cash Equivalents 145.64 Million 123.55 Million 293.82 Million 140.4 Million 96.67 Million
Short Term Investments 400.57 Million 516.59 Million 320.96 Million 472.21 Million 339.37 Million
Net Receivables - - - - -
Inventory - - - - -
Other Current Assets 8.46 Million 11.14 Million 11.49 Million 4.92 Million 4.21 Million
Total Non-Current Assets 195.34 Million 286.26 Million 501.12 Million 290.73 Million 115.37 Million
Net PPE 142.31 Million 166.26 Million 166.63 Million 124.05 Million 43.7 Million
Good Will And Intangible Assets - - - - -
Good Will - - - - -
Intangible Assets - - - - -
Long-Term Investments 48.5 Million 115.04 Million 330.53 Million 163.44 Million 68.98 Million
Tax Assets - - - - -
Other Non Current Assets 4.51 Million 4.96 Million 3.94 Million 3.23 Million 2.68 Million
Other Assets - - - - -
Total Liabilities 95.07 Million 104.3 Million 197.61 Million 189.84 Million 147.57 Million
Total Current Liabilities 34.51 Million 37.02 Million 46.73 Million 49.28 Million 22.04 Million
Account Payables 4.81 Million 3.91 Million 3.2 Million 9.39 Million 2.84 Million
Tax Payables - - - - -
Short Term Debt 6.27 Million 4.53 Million 1.16 Million 3.61 Million 344 Thousand
Deferred Revenue 20.36 Million 21.86 Million 4.98 Million 6.09 Million 4.51 Million
Other Current Liabilities 3.06 Million 6.7 Million 37.37 Million 30.17 Million 14.34 Million
Total Non Current Liabilities 60.55 Million 67.28 Million 150.88 Million 140.55 Million 125.53 Million
Long-Term Debt 56.89 Million 63.16 Million 66.65 Million 50.95 Million 27.12 Million
Deferred Revenue Non Current - - 79.66 Million 89.06 Million 98.4 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 3.66 Million 4.11 Million 4.56 Million 532 Thousand 98.4 Million
Other Liabilities - - - - -
Total Equity 654.95 Million 833.25 Million 929.78 Million 718.44 Million 408.05 Million
Stock Holders Equity 654.95 Million 833.25 Million 929.78 Million 718.44 Million 408.05 Million
Common Stock 25 Thousand 25 Thousand 24 Thousand 2000.00 1000.00
Retained Earnings -1 Billion -767.48 Million -584.36 Million -334.14 Million -129.67 Million
Accumulated other comprehensive income -94 Thousand -7.59 Million -1.62 Million 256 Thousand 454 Thousand
Common Stock Equity 654.95 Million 833.25 Million 929.78 Million 718.44 Million 408.05 Million
Capital Lease Obligation 63.16 Million 67.7 Million 67.81 Million 54.57 Million 27.46 Million
Total Investments 449.08 Million 631.63 Million 651.49 Million 635.65 Million 408.35 Million
Total Debt 63.16 Million 67.7 Million 67.81 Million 54.57 Million 27.46 Million
Net Debt -82.48 Million -55.85 Million -226 Million -85.83 Million -69.2 Million

Balance Sheet Charts